Aug 12, 2009 | Posted by: roboblogger
NicOx Reacquires Rights to PF-03187207 for Glaucoma From Pfizer
Sophia Antipolis, France, August 6, 2009. . www.nicox.com -- NicOx S.A. today announced the signature of an agreement with Pfizer Inc to reacquire the full development and commercialization rights to PF-03187207 , which has completed two phase 2 studies in patients with primary open angle glaucoma and ocular hypertension.
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
Other Recent Xalatan, Latanoprost Discussions
Search the Xalatan, Latanoprost Forum:
Search the Xalatan, Latanoprost Forum:
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| Latanoprost derivatives show help for glaucoma (Jul '07) | Mar '09 | JimOfCR | 5 |
| xalatan eye drop (Aug '08) | Aug '08 | DR-ALI | 1 |
| preservative free drops (Apr '06) | Apr '06 | harry | 1 |
Daily Horoscope for January 7
Aquarius
Avoid making promises today, or even believing in other people's promises. Today is not a good day to make commitments, as they are not likely to materialise. Taking risks is a no-no. Try to relax until the numbers are in your favour. Those pursuing their career will benefit.
|
Reach local customers. Engage a specific demographic. Maximize business-to-business opportunities. Topix can deliver your message.
|
Copyright ©2009 Topix LLC
